Pharmasum’s pipeline currently focuses on niche areas of neurology and autoimmune diseases with high unmet medical need, using our knowledge of protein kinases to design potent, specific and brain-penetrant inhibitor compounds.

The company’s cutting edge design and translational medicine engine offer a unique structure based drug discovery process.